Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
SARASOTA, Fla., May 07, 2024 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a pioneer in developing innovative intranasal pharmaceuticals […]
Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024
PLANO, Texas, May 07, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and […]
Dayforce Releases Dayforce Partner Exchange
MINNEAPOLIS and TORONTO, May 07, 2024 (GLOBE NEWSWIRE) — Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management […]
Crown Castle’s Highly Qualified Board of Directors is Driving Strategic Actions to Enhance Value
Refreshed Board Has Deep Expertise in Telecom, Towers and Fiber Industries as well as C-Suite and Investment Professional Experience Boots […]
Crane NXT Completes Acquisition of OpSec Security
Creates New Security and Authentication Technologies Segment, Consisting of Crane Currency and OpSec Security Sam Keayes Appointed Senior Vice President, […]
Meritage Homes Announces Pricing of Convertible Senior Notes
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH, “Meritage” or the “Company”), the fifth-largest homebuilder […]
Solaris Provides Update on Warintza Operations, Optimization Progress, and Appointment of Leading Consultants for the EIA and PFS
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) […]
American Shared Hospital Services Announces First Quarter 2024 Earnings Conference Call
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider […]
XPO Opens New Service Center in Las Vegas to Expand Trade Show Shipping and Strengthen Freight Transportation Across the Region
GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of LTL freight transportation in North America, […]
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results
– Reported topline data from the investigator sponsored Phase 1 trial of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma; […]
